Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
This guide discusses withdrawal rate decisions for an index fund portfolio in retirement, including portfolio diversification and contingency planning.
23,281 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Investors are shifting bets toward defense names as urban warfare tech dominates modernization plans. This piece exam...
When insider moves hit the headlines, investors seek clarity. This piece breaks down what it means when the holdings ...
Vail Resorts is signaling a strategic pivot away from the iconic $1,000 Epic Pass as season results lag and weather c...
As 2026 begins, Tesla faces pressure on deliveries while BYD battles domestic slumps but advances fast charging and o...
Apple launched the MacBook Neo at a budget price, signaling a potential breakthrough for Mac demand. This article bre...
Even as global drinking declines, Anheuser-Busch InBev shows resilience through a diversified brand mix, cost discipl...
Canadian traders face a fast-moving market in May 2026 as platforms race to lower costs and boost real-time data. Thi...
Mizuho raises Dell's price target to $300 on expected durable demand from agentic AI servers, while UBS nudges valuat...
Jefferies boosts Palo Alto Networks price target to $265 with a Buy rating as AI-driven threats compress attack timel...
A surprising uptick in the memory sector has traders asking, 'Why is SanDisk stock today?' While SanDisk isn’t traded...
AI optics stocks pull back after a prolonged rally, with Applied Optoelectronics slumps 10% as LUMENTUM and Coherent ...